Publication:
Hypercholesterolemia treatment in a patient with family hypercholesterolemia and myopathy due to carnitine palmitoyltransferase II deficiency with PCSK9 inhibitors.

dc.contributor.authorLuque Linero, P
dc.contributor.authorCastilla-Guerra, L
dc.contributor.authorRojas Marcos Rodriguez, I
dc.contributor.authorRico Corral, M A
dc.date.accessioned2023-05-03T15:13:17Z
dc.date.available2023-05-03T15:13:17Z
dc.date.issued2021-06-07
dc.identifier.doi10.1016/j.nrl.2021.05.003
dc.identifier.essn2173-5808
dc.identifier.pmid34112556
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.nrl.2021.05.003
dc.identifier.urihttp://hdl.handle.net/10668/22446
dc.journal.titleNeurologia
dc.journal.titleabbreviationNeurologia (Engl Ed)
dc.language.isoen
dc.language.isoes
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.pubmedtypeLetter
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleHypercholesterolemia treatment in a patient with family hypercholesterolemia and myopathy due to carnitine palmitoyltransferase II deficiency with PCSK9 inhibitors.
dc.title.alternativeTratamiento de la hipercolesterolemia en un paciente con hipercolesterolemia familiar y una miopatía por déficit de carnitina palmitoiltransferasa II con inhibidores de PCSK9.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files